Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip
Background: Pertussis is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis (B. pertussis). The infection is difficult to diagnose especially in underserved or resource-limited areas. We developed a low-cost and instrument-free diagnostic method for rapid and accura...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-02-01
|
Series: | EClinicalMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537019300343 |
id |
doaj-3c6469cdeda7452bb97ecd0ccfef4728 |
---|---|
record_format |
Article |
spelling |
doaj-3c6469cdeda7452bb97ecd0ccfef47282020-11-24T20:45:02ZengElsevierEClinicalMedicine2589-53702019-02-0187277Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care BiochipMaowei Dou0Natalie Macias1Feng Shen2Jennifer Dien Bard3Delfina C. Domínguez4XiuJun Li5Department of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, TX, USADepartment of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, TX, USADepartment of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, TX, USADepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USAClinical Laboratory Science, Department of Public Health Sciences, University of Texas at El Paso, 500 West University Ave, El Paso, TX 79968, USA; Corresponding authors.Department of Chemistry and Biochemistry, Biomedical Engineering, Border Biomedical Research Center, Environmental Science and Engineering, University of Texas at El Paso, 500 West University Ave, El Paso, TX 79968, USA; Corresponding authors.Background: Pertussis is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis (B. pertussis). The infection is difficult to diagnose especially in underserved or resource-limited areas. We developed a low-cost and instrument-free diagnostic method for rapid and accurate detection of B. pertussis on a point-of-care (POC) testing device. Methods: We developed a paper/polymer hybrid microfluidic biochip integrated with loop-mediated isothermal amplification (LAMP) method for the rapid and accurate detection of B. pertussis. This microfluidic approach was validated by testing 100 de-identified remnant clinical nasopharyngeal swabs and aspirates, which were confirmed to be either positive or negative for B. pertussis by a validated real-time PCR assay at the Children's Hospital Los Angeles. Findings: The instrument-free detection results could be successfully read by the naked eye within 45 min with a limit of detection (LOD) of 5 DNA copies per well. Our optimized bacterial lysis protocol allowed the direct testing of clinical samples without any complicated sample processing/preparation (i.e. DNA extraction) or the use of any equipment (e.g. centrifuges). The validation of the microfluidic approach was accomplished by testing 100 clinical samples. High sensitivity (100%) and specificity (96%) with respect to real-time PCR were achieved. Interpretation: This microfluidic biochip shows great potential for point-of-care disease diagnosis in various venues including schools and physician's offices, especially in low-resource settings in developing nations. Funding: NIH/NIAID under award number R21AI107415, NIH RCMI Pilot Grant, the Philadelphia Foundation, the Medical Center of the Americas Foundation. Keywords: Pertussis diagnosis, Point-of-care detection, Microfluidic biochip, Whooping cough, Loop-mediated isothermal amplification (LAMP)http://www.sciencedirect.com/science/article/pii/S2589537019300343 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maowei Dou Natalie Macias Feng Shen Jennifer Dien Bard Delfina C. Domínguez XiuJun Li |
spellingShingle |
Maowei Dou Natalie Macias Feng Shen Jennifer Dien Bard Delfina C. Domínguez XiuJun Li Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip EClinicalMedicine |
author_facet |
Maowei Dou Natalie Macias Feng Shen Jennifer Dien Bard Delfina C. Domínguez XiuJun Li |
author_sort |
Maowei Dou |
title |
Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip |
title_short |
Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip |
title_full |
Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip |
title_fullStr |
Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip |
title_full_unstemmed |
Rapid and Accurate Diagnosis of the Respiratory Disease Pertussis on a Point-of-Care Biochip |
title_sort |
rapid and accurate diagnosis of the respiratory disease pertussis on a point-of-care biochip |
publisher |
Elsevier |
series |
EClinicalMedicine |
issn |
2589-5370 |
publishDate |
2019-02-01 |
description |
Background: Pertussis is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis (B. pertussis). The infection is difficult to diagnose especially in underserved or resource-limited areas. We developed a low-cost and instrument-free diagnostic method for rapid and accurate detection of B. pertussis on a point-of-care (POC) testing device. Methods: We developed a paper/polymer hybrid microfluidic biochip integrated with loop-mediated isothermal amplification (LAMP) method for the rapid and accurate detection of B. pertussis. This microfluidic approach was validated by testing 100 de-identified remnant clinical nasopharyngeal swabs and aspirates, which were confirmed to be either positive or negative for B. pertussis by a validated real-time PCR assay at the Children's Hospital Los Angeles. Findings: The instrument-free detection results could be successfully read by the naked eye within 45 min with a limit of detection (LOD) of 5 DNA copies per well. Our optimized bacterial lysis protocol allowed the direct testing of clinical samples without any complicated sample processing/preparation (i.e. DNA extraction) or the use of any equipment (e.g. centrifuges). The validation of the microfluidic approach was accomplished by testing 100 clinical samples. High sensitivity (100%) and specificity (96%) with respect to real-time PCR were achieved. Interpretation: This microfluidic biochip shows great potential for point-of-care disease diagnosis in various venues including schools and physician's offices, especially in low-resource settings in developing nations. Funding: NIH/NIAID under award number R21AI107415, NIH RCMI Pilot Grant, the Philadelphia Foundation, the Medical Center of the Americas Foundation. Keywords: Pertussis diagnosis, Point-of-care detection, Microfluidic biochip, Whooping cough, Loop-mediated isothermal amplification (LAMP) |
url |
http://www.sciencedirect.com/science/article/pii/S2589537019300343 |
work_keys_str_mv |
AT maoweidou rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip AT nataliemacias rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip AT fengshen rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip AT jenniferdienbard rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip AT delfinacdominguez rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip AT xiujunli rapidandaccuratediagnosisoftherespiratorydiseasepertussisonapointofcarebiochip |
_version_ |
1716815793374625792 |